Recent studies suggest that GNG4 expression is elevated in a variety of tumours, including colorectal, colon, gastric, lung adenocarcinoma, and gallbladder cancers, and is associated with poor prognosis in patients with these cancer types (19–24). This evidence concerns the gene GNG4 and neoplasm.